Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × Docetaxel × Clear all

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

NCT00258362 2017-12-28

Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer

Phase 2 Completed

41 enrolled 10 charts

Gynecologic

Endometrial Neoplasms

NCT01461746 2017-05-31

Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer

Phase 2 Unknown

67 enrolled

Gynecologic

Endometrial Neoplasms

NCT00085332 2014-01-13

Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)

Phase 2 Completed

Gynecologic

Endometrial Neoplasms

NCT00003560 2014-01-06

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Unknown

40 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

Clinical Trials

KEYVIBE-005

Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer

Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer

Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer